MedTrace Logo

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo

NCT00367224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-04-30

No results posted yet for this study

Summary

The purpose of this study is to determine if vitiligo patients develop tolerance to ultraviolet light therapy, a type of treatment available for vitiligo.

Conditions

  • Vitiligo

Interventions

PROCEDURE

6 to 9 ultraviolet B treatments

Treatments with ultraviolet B with gradually progressive doses

PROCEDURE

Skin biopsies

4 mm punch biopsies of the skin

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Iltefat Hamzavi · Department of Dermatology, Henry Ford Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00367224 on ClinicalTrials.gov